3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Sell
9
UCLQF Quote, Financials, Valuation and Earnings
Last price:
$103.00
Seasonality move
:
-0.12%
Day range:
$103.00 - $103.00
52-week range:
$103.00 - $103.00
Dividend yield:
0.81%
P/E ratio:
37.77x
P/S ratio:
3.55x
P/B ratio:
4.05x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$29.7B
Revenue:
$8.4B
EPS (TTM):
$2.73
Analysts' Opinion
-
Consensus RatingUltraTech Cement has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, UltraTech Cement has an estimated downside of -- from its current price of $103.00.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $103.00.
Fair Value
-
According to the consensus of 0 analysts, UltraTech Cement has -- downside to fair value with a price target of -- per share.
UCLQF vs. S&P 500
-
Over the past 5 trading days, UltraTech Cement has underperformed the S&P 500 by -1.57% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
UltraTech Cement does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
UltraTech Cement revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter UltraTech Cement reported revenues of $1.9B.
Earnings Growth
-
UltraTech Cement earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter UltraTech Cement reported earnings per share of $0.34.
Enterprise value:
30.7B
EV / Invested capital:
--
Price / LTM sales:
3.55x
EV / EBIT:
26.37x
EV / Revenue:
3.67x
PEG ratio (5yr expected):
2.77x
EV / Free cash flow:
-77.52x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
19.62x
Gross Profit (TTM):
$6.7B
Return On Assets:
6.51%
Net Income Margin (TTM):
9.4%
Return On Equity:
11.43%
Return On Invested Capital:
9.13%
Operating Margin:
7.13%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $7.4B | $8.1B | $8.4B | $1.9B | $1.9B | |
| Gross Profit | $6.1B | $6.7B | $6.7B | $1.6B | $1.5B | |
| Operating Income | $1B | $981.3M | $1.1B | $212M | $133M | |
| EBITDA | $1.4B | $1.4B | $1.6B | $329.1M | $267.1M | |
| Diluted EPS | $3.04 | $2.40 | $2.73 | $0.54 | $0.34 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $2.5B | $2.2B | $2.4B | $2.8B | |
| Total Assets | $11B | $11.2B | $10.6B | $11.3B | $12.9B | |
| Current Liabilities | $2.4B | $2.7B | $2.5B | $2.9B | $3.4B | |
| Total Liabilities | $5.5B | $5B | $4.3B | $4.5B | $5.4B | |
| Total Equity | $5.5B | $6.2B | $6.3B | $6.8B | $7.5B | |
| Total Debt | $3B | $1.9B | $1.4B | $1.2B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $406M | $337.4M | |
| Cash From Investing | -- | -- | -- | -$276.9M | -$745.7M | |
| Cash From Financing | -- | -- | -- | -$151.4M | $363.7M | |
| Free Cash Flow | $896.4M | $419.2M | -$396.7M | -$88.4M | -$198.6M | |
UCLQF
Sector
Market Cap
$29.7B
$18.8M
Price % of 52-Week High
100%
59.38%
Dividend Yield
0.81%
0%
Shareholder Yield
-0.38%
1.61%
1-Year Price Total Return
--
-16.67%
Beta (5-Year)
0.037
1.056
Dividend yield:
0.81%
Annualized payout:
$0.46
Payout ratio:
30.53%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$103.00
200-day SMA
Sell
Level
$103.00
Bollinger Bands (100)
Sell
Level
103 - 103
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$103.00
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Neutral
Level
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$103.00
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-112
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.7988)
Buy
CA Score
(Annual)
Level (0.7478)
Buy
Beneish M-Score
(Annual)
Level (-2.5857)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.6707)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
UltraTech Cement Ltd produces and sells cement and cement-related products. The company generates the vast majority of its revenue in India. The company's product portfolio includes Ordinary Portland cement, Portland blast-furnace slag cement, and Portland Pozzolana cement. Ordinary Portland cement is used for a wide range of applications including concrete products, masonry, and plastering. The firm's customers are in the building and construction industries.
Stock Forecast FAQ
In the current month, UCLQF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The UCLQF average analyst price target in the past 3 months is --.
-
Where Will UltraTech Cement Stock Be In 1 Year?
According to analysts, the consensus estimate is that UltraTech Cement share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About UltraTech Cement?
Analysts are divided on their view about UltraTech Cement share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UltraTech Cement is a Sell and believe this share price will rise from its current level to --.
-
What Is UltraTech Cement's Price Target?
The price target for UltraTech Cement over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is UCLQF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for UltraTech Cement is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of UCLQF?
You can purchase shares of UltraTech Cement via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UltraTech Cement shares.
-
What Is The UltraTech Cement Share Price Today?
UltraTech Cement was last trading at $103.00 per share. This represents the most recent stock quote for UltraTech Cement. Yesterday, UltraTech Cement closed at $103.00 per share.
-
How To Buy UltraTech Cement Stock Online?
In order to purchase UltraTech Cement stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 21.98% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 6.02% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 0.25% over the past day.
